Skip to main content
. 2009 Jun 9;84(1):111–118. doi: 10.1093/cvr/cvp190

Figure 2.

Figure 2

Perturbations in levels of cardiac SGLT1 mRNA expression as measured by QPCR in diseased murine hearts relative to control. Cardiac SGLT1 expression was significantly (A) decreased in streptozotocin (STZ) treated (type 1 diabetic) FVB mice, (B) increased in ob/ob (type 2 diabetic) mice, and (C) increased in WT C57BL/6J mice after coronary artery ligation. n = 4–6 per group. Data are expressed as mean ± SE. *P < 0.05.